Gossamer Bio (GOSS) Operating Leases (2022 - 2025)
Historic Operating Leases for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $4.6 million.
- Gossamer Bio's Operating Leases fell 2715.66% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 2715.66%. This contributed to the annual value of $4.4 million for FY2024, which is 295416.67% up from last year.
- Latest data reveals that Gossamer Bio reported Operating Leases of $4.6 million as of Q3 2025, which was down 2715.66% from $4.8 million recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's Operating Leases ranged from a high of $8.5 million in Q1 2022 and a low of $144000.0 during Q4 2023
- In the last 4 years, Gossamer Bio's Operating Leases had a median value of $4.8 million in 2025 and averaged $4.8 million.
- Its Operating Leases has fluctuated over the past 5 years, first plummeted by 9582.12% in 2023, then surged by 295416.67% in 2024.
- Over the past 4 years, Gossamer Bio's Operating Leases (Quarter) stood at $3.4 million in 2022, then tumbled by 95.82% to $144000.0 in 2023, then skyrocketed by 2954.17% to $4.4 million in 2024, then rose by 5.03% to $4.6 million in 2025.
- Its Operating Leases stands at $4.6 million for Q3 2025, versus $4.8 million for Q2 2025 and $5.0 million for Q1 2025.